Savara Stock (NASDAQ: SVRA) stock price, news, charts, stock research, profile.
Open | $4.48 |
Close | - |
Volume / Avg. | 172.64K / 1.82M |
Day Range | $4.42 - $4.55 |
52 Wk Range | 3.12 - 5.70 |
Market Cap | $736.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 6.87% |
Days to Cover | 11.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Other companies in Savara’s space includes: 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Replimune Group (NASDAQ:REPL) and Mesoblast (NASDAQ:MESO).
Savara has a consensus price target of $9.86.
The stock price for Savara (NASDAQ: SVRA) is $4.475 last updated September 23, 2024 at 10:41 AM EDT.
There are no upcoming dividends for Savara.
Savara’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Savara.
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.